Fundraising Fox

Sirrus

Acquired

Loveland, US · Founded 2011 · Delaware corporation · 13 employees on LinkedIn · 4 known investors

Sirrus develops chemical building blocks based on patented methylene malonate monomers and oligomeric crosslinkers that polymerize anionically at ambient temperatures. Its technology targets high-performance coatings, adhesives, sealants, binders and other polymer products for chemical industry partners.

Also known as Bioformix · Sirrus Chemistry · Sirrus, Inc.

Founders & leadership

JU
Jeff UhrigPresident, Chief Executive Officer, Secretary and Treasurer
AM
Adam MalofskyNamed on SEC filing
BM
Bernard MalofskyNamed on SEC filing
RS
Robert SmithNamed on SEC filing
JH
John HabbertAssistant Secretary

Board

WLWilliam Lese
William LeseinBoard directorManaging Partner at Braemar Energy Ventures
DC
Doug CameronBoard director
JT
John TrbovichBoard director
RP
Robert PangbornBoard director
KD
Kieran DrainBoard director

Investors · 4

Reported raises · per SEC filings

Form D private placements

$34M disclosed across 4 rounds · 2011–2016

$5MraisedJun 2016 · 10 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Doug CameronDirector
  • John TrbovichDirector
  • John HabbertExecutive Officer, Director
  • Kieran DrainDirector
  • Jeff UhrigExecutive Officer, Director
  • Robert PangbornDirector
  • Adam MalofskyDirector
  • William LeseDirector
Offering amount
$7.5M
Amount sold
$5M
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6.6MraisedFeb 2015 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Doug CameronDirector
  • John TrbovichDirector
  • Robert PangbornDirector
  • Adam MalofskyDirector
  • John HabbertExecutive Officer, Director
  • Kieran DrainDirector
  • Jeff UhrigExecutive Officer, Director
  • William LeseDirector
Offering amount
$8.2M
Amount sold
$6.6M
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$14.3MraisedJan 2014 · 7 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff UhrigExecutive Officer, Director
  • John TrbovichDirector
  • Robert PangbornDirector
  • Bernard MalofskyExecutive Officer
  • Doug CameronDirector
  • Adam MalofskyExecutive Officer, Director
  • William LeseDirector
  • John HabbertExecutive Officer, Director
  • Kieran DrainDirector
Offering amount
$14.9M
Amount sold
$14.3M
First sale
May 2013
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8.1MraisedJan 2012 · 23 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • John TrbovichDirector
  • Kieran DrainDirector
  • Adam MalofskyExecutive Officer, Director
  • Bernard MalofskyExecutive Officer
  • William LeseDirector
  • Doug CameronDirector
  • Robert SmithExecutive Officer
  • John HabbertExecutive Officer, Director
  • Robert PangbornDirector
Offering amount
$12.6M
Amount sold
$8.1M
Minimum investment
$5K
First sale
Sep 2011
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Sirrus (formerly Bioformix) is a chemical company based in the Loveland/Greater Cincinnati area of Ohio that develops chemical building blocks based on methylene malonate monomers and their oligomeric derivatives. The materials contain multiple reactive sites and polymerize anionically and rapidly at ambient temperatures, without requiring ultraviolet light, external heat sources or high solvent loadings. The company positions this chemistry as a way to reduce the time, energy requirements, solvent use and environmental footprint of chemical and manufacturing processes.

Sirrus's materials are aimed at incorporation into high-performance coatings, paints, adhesives, sealants, encapsulants, binders and other polymer products. Product/technology brands include Chemilian and Forza, and the company previously commercialized Nexabond wood glue products. Target end industries span automotive paint lines, consumer packaged goods, packaging, wood products, construction, medical adhesives and electronics. The team consists of chemists, polymer scientists and engineers, and the company operates as a wholly owned subsidiary of Japanese chemical group Nippon Shokubai.

Founding story

The company was founded in 2009 in Loveland, Ohio as Bioformix by Adam Malofsky and Bernard Malofsky, initially attracting regional investment as it commercialized malonate-based monomer chemistry.

Business model

Sirrus manufactures methylene malonate monomers and oligomeric crosslinkers and supplies them to partner companies, which combine them with their own formulation expertise to create end products. Following a strategic shift announced in 2014, the company concentrates on its core competency of stabilizing and activating its monomers while partners in industries such as automotive, electronics and packaging handle formulation and go-to-market.

Traction

The company reported 32 employees in 2014, when its Nexabond wood glue products were commercially available and it was working with several strategic partners on resins, films, coatings and other products derived from its monomers. Its patent portfolio exceeded 30 global patents, and it has publicly described work with BASF on automotive coatings.

Latest developments

In January 2018 Sirrus relaunched its website and launched a technical blog, presented on waterborne polymer dispersions at the Waterborne Symposium, and published details of its work with BASF on methylene malonate-derived crosslinkers for automotive coatings.

Full profile — market position, technology, go-to-market, geography, history

Market position

Sirrus describes itself as a small startup with roughly 30 employees positioned as a supplier of novel reactive monomers and crosslinkers to established chemical and manufacturing companies, rather than as a producer of finished formulated products.

Ambient-temperature anionic polymerization of methylene malonate derivatives, with multiple reactive sites, that avoids UV light, external heat and high solvent loadings while retaining physical properties required in existing coatings and adhesives, backed by a portfolio of more than 30 global patents.

Technology

The patented technology centers on methylene malonate monomers and oligomeric crosslinkers, including multifunctional methylene malonates produced through transesterification of ester side groups with various diols. The monomers have multiple reactive sites and polymerize anionically at ambient temperatures, eliminating the need for UV curing, external heat or high solvent loadings, which the company links to lower cost and reduced environmental footprint. Intellectual property spans more than 30 global patents covering initiation, formulation and stabilization of the methylene malonates, process technologies and methods of application, and composition of matter for related homopolymers, copolymers and hybrid polymers. Technology brands include Chemilian and Forza. Application work includes waterborne polymer dispersions.

Go-to-market

Sirrus works through strategic partners that formulate and commercialize products built on its monomers, including collaboration with BASF on automotive coatings. It supports adoption with technical resources such as white papers, presentations, safety data sheets, testing and compliance documents, videos and a technical blog, and presents at industry events such as the Waterborne Symposium.

Researchers developing new polymer classes, formulators of coatings, paints, adhesives, sealants and encapsulants, and manufacturers in automotive, packaging, wood products, construction, medical and electronics sectors.

Geography

Operations are based in Loveland in the Greater Cincinnati area of Ohio, United States; the company's parent, Nippon Shokubai, is a global chemical company based in Japan.

History

The company was founded in 2009 as Bioformix, a Loveland, Ohio chemical startup. In December 2013 it named Jeff Uhrig chief executive officer and Kousay Said chief commercial officer, part of a strategic shift away from developing and marketing products internally toward partnering with companies in various industries. In April 2014 it renamed itself Sirrus, a reference to fast-moving cirrus clouds, chosen to reflect a mission of advancing manufacturing through chemistry and to avoid being grouped with biotechnology companies. Co-founder Adam Malofsky remained on the board and co-founder Bernard Malofsky served as chief technology officer. The company later became a wholly owned subsidiary of Nippon Shokubai. In January 2018 it relaunched its website and introduced a technical blog.

Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
EmployeesApr 201432 people
Global patentsJan 201830 patents

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 6

launches, deals, and filings
Jan 2018
Website relaunch and launch of technical blog

As part of a website relaunch, Sirrus introduced a technical blog to publish updates on its patent portfolio and technology.

source ↗

Jan 2018
Work with BASF on automotive coatings

Sirrus described working with BASF on methylene malonate-derived crosslinkers for the automotive coatings industry, based on rapid polymerization at ambient temperatures.

source ↗

Jan 2018
Sirrus presents at the Waterborne Symposium

The company presented at the Waterborne Symposium, addressing waterborne polymer dispersions as an application area for its chemistry.

source ↗

Jan 2018
Sirrus operates as wholly owned subsidiary of Nippon Shokubai

Sirrus Inc. is a wholly owned subsidiary of Nippon Shokubai, a global chemical company and supplier of monomers, functional chemicals and polymer catalysts.

source ↗

Apr 2014
Bioformix renames itself Sirrus

The Loveland, Ohio chemical startup Bioformix changed its name to Sirrus, saying the name better reflected its mission of advancing manufacturing through chemistry and helped it avoid being grouped with biotechnology companies.

source ↗

Dec 2013
Jeff Uhrig named CEO; Kousay Said named chief commercial officer

The company named Jeff Uhrig chief executive officer and Kousay Said chief commercial officer as part of a strategic shift toward partnering with companies in various industries; co-founder Adam Malofsky remained on the board and co-founder Bernard Malofsky served as chief technology officer.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities · 1

corporate structure
SirrusDelaware

In the news

Research sources · 7

primary sources listed
  • Sirrussirruschemistry.com · web

7 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Sirrus do?
Sirrus develops methylene malonate monomers and crosslinkers for coatings, adhesives, sealants and binders; a Nippon Shokubai subsidiary.
Who are Sirrus's investors?
Sirrus's investors include Braemar Energy Ventures, CincyTech, Mitsui Global Investment, Arsenal.
How much funding has Sirrus raised?
Sirrus has disclosed $34M raised across 4 rounds.
Where is Sirrus headquartered?
Sirrus is headquartered in Loveland, US.